Promptly
1 known investors
Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
Investors · 1
Frequently asked questions
- What does Promptly do?
- Promptly generates real-world clinical evidence by harmonizing and sharing patient data—including clinical records, claims data, and patient-reported outcomes—for life sciences companies, insurers, and healthcare providers. The platform combines longitudinal patient data with digital biomarkers to enable evidence generation across multiple therapeutic areas and geographies.
- Who are Promptly's investors?
- Promptly's investors include Nina Capital.